Room temperature nucleic acid amplification reaction

ABSTRACT

The present invention provides an application of a cold-active bacteriophage protein in a room temperature nucleic acid amplification reaction; the cold-active bacteriophage is selected from vB_EcoM-VR5, vB_EcoM-VR7, and vB_EcoM-VR20,vB_EcoM-VR25, or vB_EcoM-VR26, and the cold-active bacteriophage protein is a uvsX protein, a uvsY protein and a gp32 protein and/or a variant protein having corresponding functions. Preferably, the uvsX protein and the variant protein thereof are selected from any sequence of SEQ ID Nos. 1-23 or 30, the uvsY protein and the variant protein thereof are selected from any sequence of SEQ ID Nos.27-29 or 32, and the gp32 protein and the variant protein thereof are selected from any sequence of SEQ ID Nos.24-26 or 31. The present invention further provides a room temperature nucleic acid amplification reaction system containing the cold-active bacteriophage protein.

TECHNICAL FIELD

The present invention belongs to the field of biotechnology, and particularly relates to an enzyme having low-temperature activity and an application thereof for nucleic acid amplification reaction under an in vitro low temperature condition.

BACKGROUND

In vitro nucleic acid amplification is a very important technology in the field of modern life science. Since 1990, in vitro nucleic acid amplification technology has achieved rapid growth.

Moreover, the technical field further plays an increasingly important role in future life science field.

The early diagnosis of lots of human and animal diseases may be performed by nucleic acid technology, which relies on an effective in vitro nucleic acid amplification technology.

Polymerase chain reaction (PCR) is a classic in vitro nucleic acid amplification method. PCR has been put in use for more than 30 years since its naissance, and various kinds of nucleic acid testing methods having different functions have been derived on the basis of PCR, such as, Reverse Transcript PCR (RT-PCR), Quantitative PCR (qPCR), and nested-PCR. PCR reaction is as follows: double-stranded DNA is cracked into single strands under high temperature conditions, then cooled and annealed; a primer is paired with a template strand, and finally, the primer is extended at a condition of 72° C., and the above process is recycled and DNA shows exponential amplification. PCR reaction process needs to be done in an apparatus having a precise temperature control element, but such an apparatus is very expensive and requires operating personnel to possess very complicated professional skill. Therefore, the apparatus may be only provided in the laboratory or medical institution from some developed regions, which greatly limits the popularization and application of PCR-based molecular diagnostic technique. In consideration of the limitations in conventional PCR from instrument and equipment, electric power and other factors, in recent years, isothermal DNA amplification has been springing up quietly, such as, strand displacement amplification (SDA), helicase dependent amplification (HDA), nuclear acid sequence-based amplification (NASBA), loop-mediated isothermal amplification (LAMP), rolling circle amplification (RCA), and Recombinase Polymerase Amplification (RPA) [1]. The most widely used is LAMP and RPA, but LAMP and RPA reaction still needs to be performed under a specific temperature (LAMP: 60-65° C., RPA: 37-42° C.). Moreover, the reaction is comparatively sensitive to the change of temperature; the amplification efficiency will greatly reduce or fail to perform correct amplification not at a most suitable temperature.

In early stage, people have carried out in-depth studies on DNA duplication in vivo. Due to a simple structure, T4 bacteriophage will achieve rapid intracellular duplication of its genome DNA after invading into a bacterium. Therefore, predecessors serve T4 bacteriophage as a model organism for a large number of studies in virology and molecular genetics. In 1976, YASUO IMAE, et al., used a bacteriophage lysis solution protein for in vitro replication of T4 bacteriophage DNA [29]; in 1979, Sinha, et al., used T4 bacteriophage duplication-associated proteins (gene proteins 32,41,43,44, 62,45, and 61) to achieve efficient in vitro replication of double-stranded DNA, and the DNA extending rate is almost up to the amplification efficiency of 500 bases/s in vivo [2]. gp32 protein plays a pivotal role in DNA duplication,recombination and repair process of T4 bacteriophage, and the most important reason is that gp32 protein has a property of binding single-stranded DNA tightly [3]. In 1983, Formosa et al., immobilized gp32 protein on an agarose adsorption column to perform affinity chromatography on a bacterial lysate infected with T4 bacteriophage, finding that DNA polymerase (gp43 protein) and two important recombinant pathway proteins (uvsX and uvsYproteins) in T4 bacteriophage may specifically bind to gp32 protein [4]. It has been proved in the further study that uvsX protein has similar functions with recA in Escherichia coli, and has DNA-dependent ATPase activity, and may bind to single or double-stranded DNA under in vitro normal saline conditions, and may catalyze pairing with homologous double or single-stranded DNA fragments [5,6]. In the corresponding period, Deborah, et al.,expressed uvsX gene by cloning and recombination, and proved that in the presence of gp32 protein, uvsX protein is ATP-dependent and thus has the activity of replacing single-strand DNA into double-stranded DNA, thereby forming a D-Loop structure, and decomposes the substrate ATP into two products ADP and AMP [7A]. What is different from recA is that uvsX has an ATP catalytic hydrolysis rate 10-20 times of recA, moreover, the catalysate may be AMP+PP_(i) and ADP+P_(i), and ATP may be hydrolyzed more thoroughly, but recA catalyzes ATP to produce ADP+P_(ionly) [7]. gp32 protein may greatly stimulate uvsX to catalyze the activity of homologous pairing of single-stranded DNA (ssDNA). Meanwhile, uvsX may further bind to uvsY tightly [7], moreover, uvsY may improve the single-stranded DNA dependent ATPase activity by enhancing the affinity between uvsX and ssDNA [8, 9]. The homologous recombination function brought by binding uvsX to ssDNA is closely associated with the duplication process of T4 DNA; after uvsX-ssDNA binds to homologous fragments, ssDNA may serve as a primer for DNA duplication [10]. The above evidences prove that gp32, uvsX and uvsY protein play a very important role in the duplication process of T4 bacteriophage DNA. It has been found in the further study that the uvsY-ssDNA complex formed by uvsY and ssDNA may cause the change of an ssDNA structure, such that ssDNA framework is more inclined to form a uvsX-SSDNA complex. Meanwhile, ATP binding makes the structure of uvsX-ssDNA more stable [11-14]. It has been found in the further study that gp32 protein and single-stranded ssDNA form a stable gp32-ssDNA complex. But under the action of uvsY, the gp32-ssDNA complex structure has an obviously reduced stability, and the ssDNA is more inclined to form a uvsX-ssDNA complex [15].

David A. Zarlinget al. used such a characteristic to perform nucleic acid amplification in a specific segment via Escherichia coliRecA protein and SSB protein and by means of a specific primer. Piepenburg made improvements based on this and replaced Escherichia coli protein into T4 bacteriophage proteins gp32, uvsX or uvsY; bsu DNA polymerase klenow fragment or sau DNA polymerase klenow fragment is selected as DNA polymerase, and the process was named RPA amplification (recombinase polymerase amplification) [22]. Gp32 protein has a similar function as the SSB protein in bacteria, and may specifically bind an ssDNA oligonucleotide primer to form a Gp32-primer complex, such that the primer maintains a single-stranded structure. Secondly, UvsY and Gp32-primer complex form a UvsY-Gp32-primer complex, and the binding affinity between Gp32 and the primer is reduced, such that UvsX competitively binds to the primer to form a UvsX-primer complex. Thirdly, under the action of ATP, the UvsX-primer complex has the characteristic of homologously pairing with the complementary sites in template strand and replaces the strand with the same base sequence, and then binds to the complementary strand to form a D-loop structure. Fourthly, under the action of DNA polymerase, 3′ terminal exposed on the primer in the D-loop structure is extended till the end of duplication. After the above process is recycled, the target DNA fragment may achieve exponential amplification.

It is reported that RPA technology may achieve amplification under the condition of 30° C., but the amplification efficiency reduces sharply. Therefore, to further reduce the reaction temperature, the present patent performs combined screening in vitro of cold-active bacteriophage protein or amino acid mutation screening directed to proteins such as Gp32, UvsX and UvsY, DNA polymerase and creatine kinase, such that the amplification reaction may be performed efficiently at an exponential rate and a lower temperature, thus shortening the amplification time. In this way, rapid amplification may achieved merely in general indoor environment temperature without any temperature-controlled equipment. In combination with a nucleic acid testing method, the present application simplifies the equipment required by the whole nucleic acid amplification and detection and achieves more convenient operation. The scope of media for the reaction is broader, and the amplification reaction may be performed not limited to a heated medium, such as, fiber paper, nylon membrane, nitrocellulose membrane and cotton fiber ball.

SUMMARY OF THE INVENTION

The host of about 90% known T4-related bacteriophage is Escherichia coli or other enteric bacilli, and the host of the rest 10% is other bacteria, such as, Aeromonas, vibrio or Synechococcus [23]. Most of them are found in domestic sewage or wastewater, and the natural host is human or other animal intestinal tract [24]. Therefore, the optimum growth temperature is similar to the host thereof, namely, 37-40° C. [25]. According to the different optimum culture temperature of forming bacteriophage plaques, the bacteriophage is classified into three categories: more than 25° C. is called high-temperature (HT) bacteriophage, 30° C. below is low-temperature (LT) bacteriophage, and the one forming bacteriophage plaques between 15° C.−42° C. is moderate temperature (MT) bacteriophage [26]. T4 bacteriophage is a kind of typical room temperature bacteriophage.

Laura Kaliniene, et al. have successively found five cold-active bacteriophages, vB_EcoM-VR5, vB_EcoM-VR7 and vB_EcoM-VR20, vB_EcoM-VR25, and vB_EcoM-VR26. Three bacteriophages vB_EcoM-VR5, vB_EcoM-VR7 and vB_EcoM-VR20 were subjected to hemolytic plaque assay respectively at the temperature of 17° C., 24° C., 30° C., 35° C., 37° C., 39° C. and 40° C. according to the method of Seeley and Primrose [27]. The result shows that temperature sensibility of the three bacteriophages is obviously different from T4 bacteriophage, and the efficiency of plating is shown in FIG. 1 , and it is determined that the three bacteriophages have an optimum temperature of 24° C. Genome is subjected to sequencing (Enterobacteria phage vB_EcoM_VR5, Accession: KP007359.1; vB_EcoM-VR7, Accession: HM563683.1; vB_EcoM_VR20, Accession: KP007360.1; vB_EcoM_VR25, Accession: KP007361.1; vB_EcoM_VR26, Accession: KP007362.1) to obtain protein sequences associated with DNA duplication.

By comparison with alignX software (as shown in FIG. 3 ), the protein sequence derived from the cold-active bacteriophage is obviously different from T4 bacteriophage, e.g., the uvsX protein of vB_EcoM-VR5 bacteriophage has only 65.6% homology to T4.

The corresponding DNA sequence is synthesized by reference to the above genome sequence, and cloned onto a pET22b expression vector with double enzyme digestion Nde I and EcoR I, and the expressed proteins are respectively named VR5X_NHlis, VR7_25X_NHlis, VR20_26X_NHlis, VR5G_NHis, VR7G_NHlis, VR25G_NHlis, VR5Y_NHlis, VR7_25_26Y_NHlis, VR20Y_NHlis, VR7_25X_CHis, VR7G_CHis, VR7_25_26Y_CHis, and the sequences are as follows:

VR5X_NHis Mhhhhhhsdlksrlikastskmtadltksklfngrdevptripmlnialggalnaglqsgl tifaapskhfktlfgltmvaaymkkypdaiclfydsefgasesyfrsmgvdlervvhtpiq sveqlkvdmtnqleeitrgekviifidsigntaskketedalnekvvgdmtrakslkslfri vtpyltikdipcvainhtameiggmypkeimgggtgilysastvffiskrqvkdgteltgy dftlkaeksrtvkekstfpitvnfeggidpfsgllemateigfvvkpkagwynrafldettg emvqeekswrakatdcvefwgplfkhapfraaienkyklgainsikevddavndlinsr vsknvavklsgdaqsaadiendleemdlnd (SEQ ID NO. 21) VR7_25X_NHis Mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmq sgltifagpskhfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdpervi htpiqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtrak slkslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketg kelegfqfvlnaeksrmvkekskffidvkfdggidpysglldmameigfvvkpkvgw ynreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnavv daevdeliaskvekysapvgktkpsaadiendldmmedlde (SEQ ID NO. 22) VR20_26X_NHis Mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmq sgltifagpskhfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdpervi htpiqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtrak slkslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketg kelegfqfvlnaeksrmvkekskffidvkfdggidpysglldmameigfvvkpkvgw ynreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnavv daevdelisskvekysapegkskpsaadiendldmmedlde (SEQ ID NO. 23) VR5G_NHis: Mhhhhhhsmfkrrdpsqlaaqlnalkggssfssddksewklkddngvgtavirflpsk deanpspfvklvnhgfkkngqwyiesctsthgdfdscpvckymnqndsfntnnaeyk lmkrktsfwanilvikdsavpanegkvfkfrfgqkimdkinqmvevdtdigetpidvtc pfdganfvlkskkvgdfknyddskfmnqseipnindeayqaklmeemhdlskllefks fetneakfkkvvgtaalggaaakasaaadkigddldafsadldaydskpstparsttpeps vspsdddglddllagl (SEQ ID NO. 24) VR7G_NHis Mhhhhhhfkrrpadlaaslnalkggagfssddkkewklkdtdgvgsavirflpskne enpspfiklvnhgfknagqwyienctsthgdyencpvcaymnkndlyntneseyrklk rntsywanilvikdpavpsnegqvfkyrfgkkimdkinqmvevdvdmgetaidvtcp feganfvlkskmvsgyknyddskfmnqseiagindeafqkklwdemsdlnellvfksl eenqkkfskvmgtaalggaaskaaaqadklgadlddfdkdmedftsnkpaksertata pstpepsddglddllagl (SEQ ID NO. 25) VR25G_NHis: Mhhhhhhsmfkrknpadlaaslnalkggsgfssddkkewklkdtdgvgsavirflpsk neenpspfiklvnhgfknagqwyienctsthgdyencpvcaymnkndlyntneseyr klkrntsywanilvikdpavpsnegqvfkyrfgkkimdkinqmvevdvdmgetaidv tcpfeganfvlkskmvsgyknyddskfmnqseiagindeafqkklwdemsdlnellvf ksleenqkkfskvmgtaalggaaskaaaqadklgadlddfdkdmedftsskpakserta tapstpepsddglddllagl (SEQ ID NO. 26) VR5Y_NHis mhhhhhhskeieyklesfqdaldedlkidgtrlqyevqnnvllhskwlrlytnckkeimr leiqkktslkkrldfytgrgepgdevcmdqyekselktvmaadssvikidtsiqywallq dfcssaldaikargfnlktmhemrqfeagk (SEQ ID NO. 27) VR7_25_26Y_ mhhhhhhkteieyklevfqdeldadlkidgtqiqyetqnnvllhskwlrlytnckkeimr NHis leiqkktalkkrldhytgrgdpgeevcmdvyekselktvmaadssvlkidtsiqywallq dfcsaaldgvksrsfalkhmleirqfeagk (SEQ ID NO. 28) VR20Y_NHis mhhhhhhkkeieyklevfqdeldadlkidgtqlqyetqnnvllhskwlrlytnckkeim rleiqkktalkkrldhytgrgdpgeevcmdvyekselktvmaadssvlkidtsiqywall qdfcsaaldgvksrsfalkhmleirqfeagk (SEQ ID NO. 29) VR7_25X_CHis msiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmqsgltifag pskhfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdpervihtpiqsve qlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtrakslkslfrivt pffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketgkelegfqf vlnaeksrmvkekskffidvkfdggidpysglldmameigfvvkpkvgwynreyldv etgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnavvdaevdeli askvekysapvgktkpsaadiendldmmedldehhhhhh (SEQ ID NO. 30) VR7G_CHis Mfkrrnpadlaaslnalkggagfssddkkewklkdtdgvgsavirflpskneenpspfi klvnhgfknagqwyienctsthgdyencpvcaymnkndlyntneseyrklkrntsyw anilvikdpavpsnegqvfkyrfgkkimdkinqmvevdvdmgetaidvtcpfeganf vlkskmvsgyknyddskfmnqseiagindeafqkklwdemsdlnellvfksleenqk kfskvmgtaalggaaskaaaqadklgadlddfdkdmedftsnkpaksertatapstpep sddglddllaglhhhhhh (SEQ ID NO. 31) VR7_25_26Y_ mkteieyklevfqdeldadlkidgtqiqyetqnnvllhskwlrlytnckkeimrleiqkkt CHis alkkrldhytgrgdpgeevcmdvyekselktvmaadssvlkidtsiqywallqdfcsaal dgvksrsfalkhmleirqfeagkhhhhhh (SEQ ID NO. 32)

Meanwhile, the corresponding genes uvsX, uvsY and gp32 of T4 bacteriophage are synthesized, and cloned onto an expression vector pET22b by molecular biology. The expressed amino acid sequence is as follows:

Phage_T4_uvsX MHHHHHHSDLKSRLIKASTSKLTAELTASKFFNEKDVVRT KIPMMNIALSGEITGGMQSGLLILAGPSKSFKSNFGLTMVS SYMRQYPDAVCLFYDSEFGITPAYLRSMGVDPERVIHTPVQ SLEQLRIDMVNQLDAIERGEKVVVFIDSLGNLASKKETED ALNEKVVSDMTRAKTMKSLFRIVTPYFSTKNIPCIAINHTY ETQEMFSKTVMGGGTGPMYSADTVFIIGKRQIKDGSDLQG YQFVLNVEKSRTVKEKSKFFIDVKFDGGIDPYSGLLDMAL ELGFVVKPKNGWYAREFLDEETGEMIREEKSWRAKDTNC TTFWGPLFKHQPFRDAIKRAYQLGAIDSNEIVEAEVDELIN SKVEKFKSPESKSKSAADLETDLEQLSDMEEFNE (SEQ ID NO. 33) Phage_T4_uvsY MHHHHHHRLEDLQEELKKDVFIDSTKLQYEAANNVMLYS KWLNKHSSIKKEMLRIEAQKKVALKARLDYYSGRGDGDE FSMDRYEKSEMKTVLSADKDVLKVDTSLQYWGILLDFCS GALDAIKSRGFAIKHIQDMRAFEAGK (SEQ ID NO. 34) Phage_T4_GP32 MHHHHHHFKRKSTAELAAQMAKLNGNKGFSSEDKGEWK LKLDNAGNGQAVIRFLPSKNDEQAPFAILVNHGFKKNGK WYIETCSSTHGDYDSCPVCQYISKNDLYNTDNKEYSLVKR KTSYWANILVVKDPAAPENEGKVFKYRFGKKIWDKINAMI AVDVEMGETPVDVTCPWEGANFVLKVKQVSGFSNYDES KFLNQSAIPNIDDESFQKELFEQMVDLSEMTSKDKFKSFEE LNTKFGQVMGTAVMGGAAATAAKKADKVADDLDAFNVD DFNTKTEDDFMSSSSGSSSSADDTDLDDLLNDL (SEQ ID NO. 35)

A host cell BL21(DE3) is transformed according to molecular cloning technique, and induced with IPTG for expression, then repeatedly frozen and lyzed, and purified [28] by a Ni column to obtain a high-purity protein, and the high-purity protein is subjected to amplification test.

UvsX function is similar to the RecA protein of Escherichia coli, and its homologous strand transferase displacement transferase activity is dependent on ATP. Different from RecA, uvsX decomposes ATP into two products of ADP and AMP. High-concentration ADP and AMP will produce an inhibiting effect on uvsX [31]. Therefore, the product needs to be transformed into ATP, thus reducing inhibition. The energy system is formulated by reference to Hinton, D. M, Birkenkamp-Demtroder and other methods, and ATP has a concentration of 1 mM-5 mM, phosphocreatine and myokinase [32, 33]. Myokinase may be selected from rabbit myokinase and carp myokinase. Myokinase M1 type (M1-CK) has adapted to low-temperature environment and PH value with body temperature. Wu CL, et al. have found that Gly in the 268th position of rabbit myokinase is changed into Asnmyokinase to significantly enhance the the activity of myokinase to form ATP under catalysis at low temperature. Therefore, myokinase is theoretically and preferably selected from G268N variant-type myokinase or carp myokinase [34,35].

The genes are synthesized respectively by reference to the protein sequences NCBI No. AAC96092.1 and NP_001075708.1, and respectively cloned onto a pET22b expression vector by double enzyme digestion Nde I and EcoR I; the corresponding proteins are respectively named RM-CK and Carp-M1-CK, and N terminal is fused with a 6xHis tag for the convenience of purification. Meanwhile, by reference to the above literature, the RM-CK encoding gene is mutated by means of a conventional gene site mutation technique, such that G in the position 268 free of histidine-tag) amino acid of the translated protein is mutated to N.

RM-CK Mhhhhhhpfgnthnkyklnykseeeypdlskhnnhmakvltpdlykklrdketpsgftl ddviqtgvdnpghpfimtvgcvagdeesytvfkdlfdpiiqdrhggfkptdkhktdlnhen kkggddldphyvlssrvrtgrsikgytlpphcsrgerraveklsvealnsltgefkgkyyplk smteqeqqqliddhflfdkpvsplllasgmardwpdargiwhndnksflvwvneedhlr vismekggnmkevfrrfcvglqkieeifkka G hpfmwnehlgyvltcpsnlgtglrggvh vklahlskhpkfeeiltrlrlqkrgtggvdtaavgsvfdisnadrlgsseveqvqlvvdgvkl mvemekklekgqsiddmipaqk (SEQ ID NO. 36) RM-CK_G268N Mhhhhhhpfgnthnkyklnykseeeypdlskhnnhmakvltpdlykklrdketpsgftl ddviqtgvdnpghpfimtvgcvagdeesytvfkdlfdpiiqdrhggfkptdkhktdlnhen lkggddldphyvlssrvrtgrsikgytlpphcsrgerraveklsvealnsltgefkgkyyplk smteqeqqqliddhflfdkpvsplllasgmardwpdargiwhndnksflvwvneedhlr vismekggnmkevfrrfcvglqkieeifkka

hpfmwnehlgyvltcpsnlgtglrggvh vklahlskhpkfeeiltrlrlqkrgtggvdtaavgsvfdisnadrlgsseveqvqlvvdgvkl mvemekklekgqsiddmipaqk (SEQ ID NO. 37) Carp-M1-CK mhhhhhhpfgnthnnfklnysvddefpdlakhnnhmakvltkemygklrdkqtstgftl ddaiqtgvdnpghpfimtvgcvagdeesyevfkdlfdpvisdrhggykatdkhktdlnfe nlkggddldpnyvlssrvrtgrsikgyalpphnsrgerraveklsvealnsldgefkgkyyp lksmtdaeqeqliadhflfdkpvsplllaagmardwpdargiwhnenktflvwvneedhl rvismqpggnmkevfrrfcvglqrieeifkkhnhgfmwnehlgfiltcpsnlgtglrggvhv klpklsthakfdeiltrlrlqkrgtggvdtasvggvfdisnadrigssevdqvqcvvdgvklm iemekklekgesidsmipaqk (SEQ ID NO. 38)

Amplification reaction conditions are referring to the Sinha, N. K. method; Mg2+ concentration is 5-20 mM, K+ concentration is 20-120 mM, preferably, the concentration is 40-80 mM; dNTP concentration is 100 uM-1000 uM; preferably, the concentration is within 300 uM-600 uM.

To further improve the reaction efficiency, it attempts reducing temperature to obtain higher reaction efficiency. By synthesizing DNA directed mutation library and screening, double enzyme digestion Nde I and EcoR I are used for cloning onto a pET22b expression vector, and a plurality of protein variants having in vitro amplification activity are obtained after expression and purification; these variant proteins are respectively named VRX_Variant1, VRX_Variant2 . . . . . . numbered consecutively to VRX_Variant20. The expressed amino acid sequences are respectively as follows:

VRX_ Mhhhhhhsdlksrlikastskmtadltksklfngrdevptripmlnialggalnaglqsglt Variant 1 ifaapsksfktlfgltmvaaymkkypdaiclfydsefgasesyfrsmgvdlervvhtpiqs veqlkvdmtnqleeitrgekviifidsigntaskketedalnekvvgdmtrakslkslfrivt pyltikdipcvainhtameiggmypkeimgggtgilysastvffiskrqvkdgteltgydf tlkaeksrtvkekstfpitvnfeggidpfsgllemateigfvvkpkagwynrafldettge mvqeekswrakatdcvefwgplfkhapfraaienkyklgainsikevddavndlinsrv sknvavklsgdaqsaadiendleemdlnd (SEQ ID No. 1) VRX_ Mhhhhhhsdlksrlikastskmtadltksklfngrdevptripmlnialggalnaglqsglt Variant 2 ifagpskhfktlfgltmvaaymkkypdaiclfydsefgasesyfrsmgvdlervvhtpiq sveqlkvdmtnqleeitrgekviifidsigntaskketedalnekvvgsmtrakslkslfriv tpyltikdipcvainhtameiggmypkeimgggtgilysastvffiskrqvkdgteltgyd ftlkaeksrtvkekstfpitvnfeggidpfsgllemateigfvvkpkagwynrafldettge mvqeekswrakatdcvefwgplfkhapfraaienkyklgainsikevddavndlinsrv sknvavklsgdaqsaadiendleemdlnd (SEQ ID No. 2) VRX_ mhhhhhhsdlksrlikastskmtadltksklfngrdevptripmlnialggalnaglqsglt Variant 3 ifagpsksfktlfgltmvaaymkkypdaiclfydsefgisesyfrsmgvdlervvhtpiqs veqlkvdmtnqleeitrgekviifidsigntaskketedalnekvvgsmtrakslkslfrivt pyltikdipcvainhtameiggmypkeimgggtgilysastvffiskrqvkdgteltgydf tlkaeksrtvkekstfpitvnfeggidpfsgllemateigfvvkpkagwynrafldettge mvqeekswrakatdcvefwgplfkhapfraaienkyklgainsikevddavndlinsrv sknvavklsgdaqsaadiendleemdlnd (SEQ ID No. 3) VRX_ mhhhhhhsdlksrlikastskmtadltksklfngrdevptripmlnialggalnaglqsglt Variant 4 ifagpskhfktlfgltmvaaymkkypdaiclfydsefgisesyfrsmgvdlervvhtpiqs veqlkvdmtnqleeitrgekviifidsigntaskketedalnekvvgdmtrakslkslfrivt pyltikdipcvainhtameiggmypkeimgggtgilysastvffiskrqvkdgteltgydf tlkaeksrtvkekstfpitvnfeggidpfsgllemateigfvvkpkagwynrafldettge mvqeekswrakatdcvefwgplfkhapfraaienkyklgainsikevddavndlinsrv sknvavklsgdaqsaadiendleemdlnd (SEQ ID No. 4) VRX_ Mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmq Variant 5 sgltifagpsksfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdpervih tpiqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtrakt mkslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketg kelegfqfvlnaeksrmvkekskffidvkfdggidpysglldmameigfvvkpkvgw ynreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnavv daevdeliaskvekysapvgktkpsaadiendldmmedlde (SEQ ID No. 5) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmqs Variant 6 gltifagpskhfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdperviht piqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtraktm kslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketgk elegfqfvlnaeksrmvkekskffidvkfdggidpysglldmameigfvvkpkvgwy nreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnavvd aevdeliaskvekysapegktkpsaadiendldmmedlde (SEQ ID No. 6) VRX_Var mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldgg 7 mqsgltifagpsksfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdper vihtpiqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtra ktmkslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqike tgkelegfqfvlnaeksrmvkekskffidvkfdggidpysglldmameigfvvkpkvg wynreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnev vdaevdeliaskvekysapvgktkpsaadiendldmmedlde (SEQ ID No. 7) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldgg Variant 8 mqsgltifagpskhfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdpe rvihtpiqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvsdmtr aktmkslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqik etgkelegfqfvlnaeksrmvkekskffidvkfdggidpysglldmameigfvvkpkv gwynreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsne vvdaevdeliaskvekysapegktkpsaadiendldmmedlde (SEQ ID No. 8) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldgg Variant 9 mqsgltifagpsksfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdper vihtpiqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtra kslkslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiket gkelegfqfvlnaeksrmvkekskffidvkfdggidpysglldmameigfvvkpkvg wynreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnav vdaevdelisskvekysapegkskpsaadiendldmmedlde (SEQ ID No. 9) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldgg Variant 10 mqsgltifagpskhfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdpe rvihtpiqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvsdmtr akslkslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqik etgkelegfqfvlnaeksrmvkekskffidvkfdggidpysglldmameigfvvkpkv gwynreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsna vvdaevdelisskvekysapegkskpsaadiendldmmedlde (SEQ ID No. 10) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmqs Variant 11 gltifagpsksfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdperviht piqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvsdmtraktm kslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketgk elegfqfvlnaeksrmvkekskffidvkfdggidpysglldmameigfvvkpkvgwy nreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnavvd aevdelisskvekysapegkskpsaadiendldmmedlde (SEQ ID No. 11) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmqs Variant 12 gltifagpskhfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdperviht piqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvsdmtraktm kslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketgk elegfqfvlnaeksrmvkekskffidvkfdggidpysglldmameigfvvkpkvgwy nreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnevvd aevdelisskvekysapegkskpsaadiendldmmedlde (SEQ ID No. 12) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmqs Variant 13 gltifagpsksfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdperviht piqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtraksl kslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketgk elegfqfvlnaeksrmvkekskfkidvkfdggidpysglldmameigfvvkpkvgwy nreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnavvd aevdeliaskvekysapvgktkpsaadiendldmmedlde (SEQ ID No. 13) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmqs Variant 14 gltifagpskhfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdperviht piqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtraksl kslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketgk elegfqfvlnaeksrmvkekskfkidvkfdggidpysglldmameigfvvkpkvgwy nreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnavvd aevdeliaskvekysapvgktkpsaadiendldmmedlde (SEQ ID No. 14) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmqs Variant 15 gltifagpsksfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdperviht piqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtraktm kslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketgk elegfqfvlnaeksrmvkekskfkidvkfdggidpysglldmameigfvvkpkvgwy nreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnevvd aevdeliaskvekysapvgktkpsaadiendldmmedlde (SEQ ID No. 15) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmqs Variant 16 gltifagpskhfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdperviht piqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtraktm kslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketgk elegfqfvlnaeksrmvkekskfkidvkfdggidpysglldmameigfvvkpkvgwy nreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnevvd aevdeliaskvekysapvgktkpsaadiendldmmedlde (SEQ ID No. 16) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmqs Variant 17 gltifagpsksfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdperviht piqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtraksl kslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketgk elegfqfvlnaeksrmvkekskfkidvkfdggidpysglldmameigfvvkpkvgwy nreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnavvd aevdelisskvekysapegkskpsaadiendldmmedldelde (SEQ ID No. 17) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldgg Variant 18 mqsgltifagpskhfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdpe rvihtpiqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvsdmtr akslkslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqik etgkelegfqfvlnaeksrmvkekskfkidvkfdggidpysglldmameigfvvkpkv gwynreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsna vvdaevdelisskvekysapegkskpsaadiendldmmedldelde (SEQ ID No. 18) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmqs Variant 19 gltifagpsksfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdperviht piqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvgdmtraktm kslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketgk elegfqfvlnaeksrmvkekskfkidvkfdggidpysglldmameigfvvkpkvgwy nreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnevvd aevdelisskvekysapegkskpsaadiendldmmedlde (SEQ ID No. 19) VRX_ mhhhhhhsiadlksrlikastskmtatltkskffndkdvvrtkipmlniaisgaldggmqs Variant 20 gltifagpskhfksnmgltmvsaymnkypeaiclfydsefgiteaylramkvdperviht piqsveqlkvdmvnqleaiergekviifidsignmaskketedalnekvvsdmtraktm kslfrivtpffsikdipcvavnhtietiemysktvmtggtgvmysadtvfiigkrqiketgk elegfqfvlnaeksrmvkekskfkidvkfdggidpysglldmameigfvvkpkvgwy nreyldvetgemvreekswrakdtnctefwgplfkhepfrdaikrhyqlgaidsnevvd aevdelisskvekysapegkskpsaadiendldmmedldelde (SEQ ID No. 20)

Further, the room temperature amplification reaction system is constructed as follows:

Reaction reagent Final concentration ris(hydroxymethyl) aminomethane-acetic acid 50-100 mM buffer solution Potassium acetate 50-100 mM Magnesium acetate 5-20 mM Dithiothreitol 1-10 mM Polyethylene glycol (molecular weight: 1450-20000) 2.5%-12%  ATP 1-10 mM Phosphocreatine 10-50 mM Creatine kinase 20-150 ng/uI Cold-active bacteriophage uvsX 200-600 ng/uI Cold-active bacteriophage gp32 200-1000 ng/uI Cold-active bacteriophage uvsY 20-100 ng/uI Staphylococcus aureus polymerase I klenow / fragment (exo−) Bacillus subtilis (exo−) 8 Units dNTP 450 uM Forward primer 100 nM-600 nM Reverse primer 100 nM-600 nM

TemplateCell lysis template/genome extraction/plasmid

Reaction conditions are as follows: 25 uI, amplification temperature: 20-45° C. A water bath, a thermostatic equipment or PCR instrument is taken. The reaction endpoint is monitored by agarose gel electrophoresis, Sybr green I or a specific probe. During Sybr green I monitoring, the reaction system has an increased final concentration of 0.3-0.5x Sybr green I. The reaction time may be within 20-40 min, and fluorescence is read every 30 s, and the fluorescent channel is FAM/HEX. The detection instrument may be ABI7500, FTC-3000, Bio-Rad CFX MiniOpticon System, GenDx thermostatic fluorescence detector GS8, or the like. For example, when a specific probe is used to detect the amplification system, an exonuclease III or an endonuclease IV is added to the reaction, and the reaction has a final concentration of 50-100 ng/uI, and the fluorescent-labeled probe has a final concentration of 120 nM. Probe labeling is designed and synthesize by reference to [22]. The fluorescence detection may be performed via ABI7500,FTC-3000, Bio-Rad CFX MiniOpticonSystemOpticon System, GenDx thermostatic fluorescence detector GS8, or the like.

The Present Invention has the Following Beneficial Effects:

the cold-active bacteriophage protein provided by the present invention is applied in room temperature nucleic acid amplification reaction, which may not only achieve nucleic acid amplification and detection at a lower temperature, but also may further improve detection sensitivity, capable of detecting 100 copies/uI nucleic acid.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows efficiency of plating tests VR5, VR7, VR20 and T4 (control) at different temperatures.

FIG. 2 shows phylogenetic analysis of genome Geneious v5.5.

FIG. 3 shows uvsX sequence alignment between different species.

FIG. 4 is a curve graph showing isothermal amplification performed by an Enterobacteria phage vB_EcoM_VR5 amplification system.

FIG. 5 shows a curve graph showing isothermal amplification performed by an Enterobacteria phage vB_EcoM_VR7 amplification system.

FIG. 6 shows a curve graph showing isothermal amplification performed by a mixed protein amplification system derived from different species.

FIG. 7 shows electrophoretogram of an amplified product obtained by low temperature amplification by means of Enterobacteria phage vB_EcoM_VR5 amplification system and RPA (Recombinase polymerase amplification ) technology; strips 1, 2 and 3 are results respectively amplified by means of a RPA amplification reagent (TALQBAS01) at 20° C.; strips 4, 5 and 6 are results respectively amplified by means of a RPA amplification reagent (TALQBAS01) at 25° C.; strips 7, 8 and 9 are results respectively amplified by means of an Enterobacteria phage vB_EcoM_VR5 bacteriophage protein at 20° C.; and strips 10, 11 and 12 are results respectively amplified by means of an Enterobacteria phage vB_EcoM_VR5 bacteriophage at 25° C.

FIG. 8 shows a curve graph showing isothermal amplification performed by a variant-type creatine kinase and wild-type creatine kinase amplification system.

FIG. 9 shows a curve graph showing isothermal amplification performed by different polymerases in the reaction system.

FIG. 10 shows a detection curve graph of sensitivity.

FIG. 11 is a curve graph showing isothermal amplification performed by different uvsX variants respectively in the reaction system.

FIG. 12 shows influences of different temperatures on the amplification efficiency of a cold-active bacteriophage protein amplification system.

FIG. 13 is a curve graph showing isothermal amplification of a cell mycoplasma-contaminated sample detected by 450ng/uVRX_Variant1, 550ng/uI VR5G_NHis, 60ng/uI VR5Y_NHisamplification system.

DETAILED DESCRIPTION OF THE EMBODIMENTS

To describe the objective, technical solution and advantages of the present invention more clearly and apparently, the present application will be further described specifically by reference to the drawings and detailed embodiments. The following examples are only used to describe the present invention, but not intended to limit the scope of the present invention.

Example I Construction of a Recombinant Protein Expression Vector, Protein Expression and Purification

The corresponding gene sequences were designed and synthesized respectively according to the NCBI genome sequences (Enterobacteria phage vB_EcoM_VR5, Accession: KP007359.1; vB_EcoM-VR7, Accession: HM563683.1; vB_EcoM_VR20, Accession: KP007360.1; vB_EcoM_VR25, Accession: KP007361.1; vB_EcoM_VR26, Accession: KP007362.1), and cloned onto a pET22b expression vector respectively by double enzyme digestion Nde I and EcoR I, where if a C terminal of the corresponding protein of the gene sequence was fused with 6 histidine-tag, gene+Chis was named, if an N terminal was was fused with 6 histidine-tag, gene+NHis was named; gene number was added simultaneously when the amino acid sequences were consistent among different virus strains, e.g., VR7_25_26Y_CHis, showing that the uvsY amino acid sequences of the three vB_EcoM_VR7, vB_EcoM_VR25 and vB_EcoM_VR26 were consistent, and the protein corresponding to the number was the protein with the addition of 6XHis tags on the C terminal. The expressed proteins were constructed and synthesized, including VR5X_NHis, VR7_25X_NHis, VR20_26X_NHis, VR5G_NHis, VR7G_NHis, VR25G_NHis, VR5Y_NHis, VR7_25_26Y_NHis, VR20Y_NHis, VR7_25X_CHis, VR7G_CHis, VR7_25_26Y_CHis and other corresponding plasmid vectors. A host cell BL21(DE3) was transformed according to molecular cloning technique, and induced with IPTG for expression, then repeatedly frozen and lyzed, and purified [28] by a Ni column to obtain a high-purity protein, and the high-purity protein was subjected to amplification test.

Example II Construction of an Enterobacteria Phage vB_EcoM VR5 Amplification System

The reaction reagent and concentration thereof were as follows: 30 mMtris(hydroxymethyl) aminomethane-acetic acid buffer solution, 60 mM potassium acetate, 20 mM magnesium acetate, 2 mMdithiothreitol, 5% polyethylene glycol (molecular weight: 1450-20000), 3 mM ATP, 30 mM phosphocreatine, 90 ng/ulcreatine kinase, 200-600 ng/uI VR5X_NHis protein, 200-1000 ng/uI VR5G_NHis protein, 60 ng/uI VR5Y NHis protein, 8 Units Staphylococcus aureus polymerase I klenow fragment (exo-), 450 uMdNTP, 250 nM forward primer: peu-F:5′-GCGAACGGGTGAGTAACACGTATCCAATCT-3′ (SEQ ID NO. 39, 250 nM reverse primer: peu-R1:5′-AGCCATTACCTGCTAAAGTCATTCTTCCCAAA-3′ (SEQ ID NO. 40), and 10 ng/uI Mycoplasma pneumoniae genome DNA template, and the Sybr Green I had a final concentration of 0.4x. Reaction conditions were as follows: 20 uI, amplification temperature was 30° C. GenDx thermostatic fluorescence amplifier (specification: GS8) (http://www.gendx.cn/goods.php?id=64) was taken. The amplified result was real-timely detected by Sybr green I at the reaction endpoint. Amplification time: 30 min.

The amplified result was shown in FIG. 4 .

S1: VR5G_NHis protein, 1000 ng/uI VR5X_NHis protein, 300 ng/ul

S2: VR5G_NHis protein, 800 ng/uI VR5X_NHis protein, 400 ng/ul

S3: VR5G_NHis protein, 600ng/uI VRSX_NHis protein, 300 ng/ul

S4: VR5G_NHis protein, 400 ng/uI VR5X_NHis protein, 200 ng/ul

S5: VR5G_NHis protein, 200 ng/uI VR5X_NHis protein, 600 ng/uI

VR5Y NHis protein, 60 ng/uI, and other reagent components were consistent in this example.

The result shows that low temperature protein may be amplified directed to a specific template and be chimeric onto double strands by Sybr Green I, then a fluorescence signal was gave out to read and obtain the amplification curve by the fluorescence signal. The low temperature protein had inconsistent amplification efficiency at different concentrations in the solution.

Example III Construction of an Enterobacteria Phage vB_EcoM VR7 Amplification System

The reaction reagent and concentration thereof were as follows: 100 mMtris(hydroxymethyl) aminomethane-acetic acid buffer solution, 120 mM potassium acetate, 15 mM magnesium acetate, 6 mMdithiothreitol, 6% polyethylene glycol (molecular weight: 1450-20000), 2 mM ATP, 40 mM phosphocreatine, 75 ng/ulcreatine kinase, 400 ng/uI VR7_25X_NHis or VR7_25X_CHis protein, 480 ng/uI VR7G_NHis or VR7G_CHis protein, 80 ng/uI VR7_25_26Y NHis or VR7_25_26Y_CHis protein, 8 Units Bacillus subtilis polymerase I klenow fragment (exo-), 450 uMdNTP, 50 ng/ulexo excision enzyme III, 250 nM forward primer ARMP-F, 250 nM reverse primer ARMP-R,120 nM fluorescent probe, about 25 ng/uI arginine mycoplasma genome DNA template, and primer and probe sequences were respectively as follows:

ARMP-F: (SEQ ID NO. 41) 5′-AGCATGTGGTTTAATTTGATGTTACGCGG-3′ ARMP-R:  (SEQ ID NO. 42) 5′-CCATGCACCATCTGTCACTCCGTTAACCTCCG-3′ ARMP-PB: (SEQ ID NO. 43) 5′-TGTTACGCGGAGAACCTTACCCAC(Fam-dT)(THF)T(BHQ1-dT) GACATCCTTCGCAAT-3′

Reaction conditions were as follows: 50 uI, amplification temperature was 40° C.

GenDx thermostatic fluorescence amplifier (specification: GS8) was taken. The amplified result was shown in FIG. 5 .

S1/S2 reaction well: 400 ng/uI VR7_25X_NHis protein, 480 ng/uI VR7G_NHis protein; 80 ng/uI VR7_25_26Y_NHis protein.

S3/S4 reaction well: 400 ng/uI VR7_25X_CHis protein,480ng/uI VR7G_CHis protein, 80 ng/uI VR7_25_26Y_CHis protein.

S5 reaction well: 400 ng/uI VR7_25X_NHis protein, 480 ng/uI VR7G_CHis protein, 80 ng/uI VR7_25_26Y_NHis protein.

S6 reaction well: 400 ng/uI VR7_25X_CHis protein, 480 ng/uI VR7G_CHis protein, 80 ng/uI VR7_25_26Y_NHis protein.

The amplification result shows that even through the amplified fluorescence signal height value has certain differences, the detection threshold of the fluorescent amplification signal (the response time of the change of the fluorescence signal value might be monitored, TT, Threshold Time) was basically consistent. It is proved that the His protein tag has no obvious difference on the protein activity influence at the N-terminal or C-terminal of the fusion protein under the same protein concentration.

Example IV Construction of a Mixed Protein Amplification System Derived from Different Species

Protein sequences derived from five different virus strains were mixed to test whether the mixed protein derived from different strains could be amplified. The reaction reagent and concentration thereof were as follows: 50 mMtris(hydroxymethyl) aminomethane-acetic acid buffer solution, 80 mM potassium acetate, 20 mM magnesium acetate, 2 mMdithiothreitol, 6% polyethylene glycol (molecular weight: 1450-20000), 2 mM ATP, 30 mM phosphocreatine, 60 ng/ulcreatine kinase, 400 ng/uI VR5X_NHis, VR7_25X_NHis or VR20_26X_NHis protein, 600 ng/uI VR7G_NHis or VR25G_NHis protein, 55 ng/uI VR7_25_26Y_NHis or VR20Y_NHis protein, 8 Units Staphylococcus aureus polymerase I klenow fragment (exo-), 450 uMdNTP, 50 ng/ulexo excision enzyme III, 400 nM forward primer susF, 400 nM reverse primer susR,120 nM fluorescent probe susPB, about 15 ng/uI swine genome DNA template (or NTC as control, replaced by the same volume of ddH2O); the reaction conditions were as follows: 50 uI, amplification temperature: 36° C. GenDx thermostatic fluorescence amplifier (specification: GS8) was taken.

Primer and probe sequences were as follows:

susF: (SEQ ID NO. 44) 5′-AGAGATCGGGAGCCTAAATCTCCCCTCAATGG-3′ susR: (SEQ ID NO. 45) 5′-TCGAGATTGTGCGGTTATTAATGAGTCGTTTGGG-3′ susPB: (SEQ ID NO. 46) 5′-TGCCACAACTAGATACATCCACATGATTCAT(FAM-dT)(THF) CAA(BHQ1-dT)TACATCAATAAT(C3-SPACER)- 3′

The result was shown in FIG. 6 . The amplification result proves that the uvsX protein, uvsY protein, and GP32 protein derived from different strains are added to the reaction according to a certain ratio; proteins from different sources may also be interacted to participate in primer binding and melting; under the action of polymerase, amplification is performed directed to a specific template. The protein concentration is consistent, but there are large differences in the amplification efficiency, which proves that proteins from different sources have inconsistent interaction ability.

S1/S2: VR5X_NHis VR25G_NHis VR7_25_26Y_NHis S3/S4: VR5X_NHis VR25G_NHis VR20Y_NHis S5/S6: VR7_25X_NHis VR25G_NHis VR7_25_26Y_NHis S7/S8: VR20_26X_NHis VR25G_NHis VR20Y_NHis

S1/S3/S5/S7 was a template with the addition of genome DNA. S2/S4/S6/S8 was NTC negative control. (FIG. 6 a )

S1/S2: VR5X_NHis VR7G_NHis VR7_25_26Y_NHis S3/S4: VR5X_NHis VR7G_NHis VR20Y_NHis S5/S6: VR5X_NHis VR25G_NHis VR7_25_26Y_NHis S7/S8: VR20_26X_NHis VR25G_NHis VR7_25_26Y_NHis

S1/S3/S5/S7 was NTC negative control. S2/S4/S6/S8 was a template with the addition of genome DNA. (FIG. 6 b )

Example V Influence of Different Temperatures on Amplification Efficiency Tested by the Enterobacteria Phage vB_EcoM VR5 Amplification System

The Enterobacteria phage vB_EcoM_VR5 amplification system was used to test influences of different temperatures on amplification efficiency, and subjected to parallel comparison of amplification efficiency at low temperature with recombinase polymerase amplification (RPA). Enterobacteria phage vB_EcoM_VR5 amplification reaction reagent and concentration thereof were as follows: 20 mMtris(hydroxymethyl) aminomethane-acetic acid buffer solution, 120 mM potassium acetate, 10 mM magnesium acetate, 8 mMdithiothreitol, 5% polyethylene glycol (molecular weight: 20000), 3 mM ATP, 20 mM phosphocreatine, 30 ng/ulcreatine kinase, 350 ng/uI VR5X_NHis protein, 500 ng/uI VR5G_NHis protein, 50 ng/uI VR5Y_NHis protein, 10 Units Bacillus subtilis polymerase I klenow fragment (exo-), 450 uMdNTP, 250 nM forward primer: peu-F:5′-GCGAACGGGTGAGTAACACGTATCCAATCT-3′(SEQ ID NO. 47), 250 nM reverse primer: peu-R1:5′-AGCCATTACCTGCTAAAGTCATTCTTCCCAAA-3′(SEQ ID NO. 48), and about 100 pg/uI plasmid template carrying a segment of Mycoplasma pneumoniae 16srDNA gene sequence; the reaction conditions were as follows: 50 uI, and the amplification temperature was respectively configured into two temperatures: 20° C. and 25° C. A reagent TwistDx (www.twistdx.co.uk, Cat.No.: TALQBAS01) was used as control for the RPA technology; and products are used in strict accordance with the instruction. Three repeats were configured to each test. The reaction temperature was controlled by a water bath kettle; 1 h after reaction, the protein was inactivated immediately at a high temperature of 80° C.; the amplified product was precipitated by alcohol and then recycled, and dissolved by 20 uI TE; 10 uI recovered product was taken to detect the amplification result by gel electrophoresis, as shown in FIG. 7 . The sequence carrying the Mycoplasma pneumoniae 16srDNA segment gene was as follows:

(SEQ ID NO. 49) 5′-AATACTTTAGAGGCGAACGGGTGAGTAACACGTATCCAATCTACCT TATAATGGGGGATAACTAGTTGAAAGACTAGCTAATACCGCATAAGAAC TTTGGTTCGCATGAATCAAAGTTGAAAGGACCTGCAAGGGTTCGTTATT TGATGAGGGTGCGCCATATCAGCTAGTTGGTGGGGTAACGGCCTACCAA GGCAATGACGTGTAGCTATGCTGAGAAGTAGAATAGCCACAATGGGACT GAGACACGGCCCATACTCCTACGGGAGGCAGCAGTAGGGAATTTTTCAC AATGAGCGAAAGCTTGATGGAGCAATGCCGCGTGAACGATGAAGGTCTT TAAGATTGTAAAGTTCTTTTATTTGGGAAGAATGACTTTAGCAGGTAAT GGCTAGAGTTTGACTGTACCATTTTGAATAAGTGACGACTAACTATGTG CCAGCAGTCGCGGTAATACATAGGTCGCAAGCGTTATCCGGATTTATTG GGCGTAAAGCAAGCGCAGGCGGATTGAAAAGTCTGGTGTTAAAGGCAGC TGCTTAACAGTTGTATGCATTGGAAACTATTA-3′

The sequence was cloned onto a pUC57 vector, and the terminal sites were cut by an EcoR V enzyme.

It can be seen from the comparison of the reaction diagram that the amplification efficiency of the enzyme derived from low temperature species is obviously higher than that of T4 bacteriophage at low temperature of 20° C. and 25° C.

Based on the electrophoretic results of the amplification, the protein amplification efficiency derived from Enterobacteria phage vB_EcoM_VR5 bacteriophage is obviously superior to the amplification efficiency derived from T4 bacteriophage.

Example VI Influence of a Creatine Kinase Protein Variant Site on the Amplification Reaction

The reaction reagent and concentration thereof were as follows: 30 mMtris(hydroxymethyl) aminomethane-acetic acid buffer solution, 60 mM potassium acetate, 8 mM magnesium acetate, 4 mMdithiothreitol, 3% polyethylene glycol (molecular weight: 1450-20000), 3 mM ATP, 50 mM phosphocreatine, 30-50 ng/uI RM-CK/RM-CK_G268N/Carp-M1-CK, 360 ng/uI VR7_25X_NHis protein, 500 ng/uI VR7G_NHis protein, 60 ng/uI VR7_25_26Y_NHis protein, 8 Units Bacillus subtilis polymerase I klenow fragment (exo-), 450 uMdNTP, 250 nM forward primer susF, 250 nM reverse primer susR, about 10 ng/uI pork tissue genome DNA template, a probe susPB was used for detection, nfo incision enzyme IV was used, and the final concentration was 130 ng/uI. Reaction conditions were as follows: 25 uI, amplification temperature was 32° C. The reaction was performed on a GenDx GS8 fluorescence amplifier, and the fluorescence scanning interval was 60 S, and the reaction time was 40 min. The result was shown in FIG. 8 .

susF: (SEQ ID NO. 50) 5′-AGAGATCGGGAGCCTAAATCTCCCCTCAATGG-3′ susR: (SEQ ID NO. 51) 5′-TCGAGATTGTGCGGTTATTAATGAGTCGTTTGGG-3′ susPB: (SEQ ID NO. 52) 5′-TGCCACAACTAGATACATCCACATGATTCAT(FAM-dT)(THF) CAA(BHQ1-dT)TACATCAATAAT(C3-SPACER)-3′ S1: RM-CK_G268N/ 50 ng/μI S2: RM-CK_G268N/ 30 ng/μI S3: RM-CK/ 50 ng/μI S4: RM-CK/, 30 ng/μI; S5: Carp-M1-CK/ 50 ng/μI S6: Carp-M1-CK, 30 ng/μI

The test shows that in the reaction system using the enzyme of the present invention, the variant whose G is mutated into N in position 268 has amplification efficiency superior to the wild-type RM-CK.

Example VII Influence of Different Polymerases on Amplification Efficiency

The reaction system was as follows: 300 ng/uI VR7_25X_NHis protein, 400 ng/uI VR7G_CHis protein, 50 ng/uI VR7_25_26Y_NHis protein, 100 ng/uI polymerase (Staphylococcus aureus polymerase I klenow fragment (exo-)/Bacillus subtilis polymerase I klenow fragment (exo-)/Escherichia coli polymerase klenow fragment (exo-)/Pseudomonas fluorescens polymerase I klenow fragment (exo-); other reaction reagents and concentration thereof were the same as those in Example V, and Sybr Green I 0.4X was added additionally, and the amplification temperature was 33° C. The reaction was performed on a GenDx GS8 fluorescence amplifier, and the fluorescence scanning interval was 30 S, and the reaction time was 20 min.

The amplified result was shown in FIG. 9 .

S1/S2: Staphylococcus aureus polymerase I klenow fragment (exo-)

S3/S4: Bacillus subtilis polymerase I klenow fragment (exo-)

S5/S6: Escherichia coli polymerase klenow fragment (exo-)

S7/S8: Pseudomonas fluorescens polymerase I klenow fragment (exo-)

S1/S3/S5/S7 was a template with the addition of genome DNA. S2/S4/S6/S8 was NTC negative control.

Based on the reaction result, Escherichia coli polymerase klenow fragment (exo-) has slightly low amplification efficiency, while the other three DNA polymerases have higher amplification efficiency.

Example VIII Lower Limit of Detection of the Amplification Sensitivity Tested at a Low Temperature of 35° C.

The reaction reagent and concentration thereof were as follows: 50 mMtris(hydroxymethyl) aminomethane-acetic acid buffer solution, 100 mM potassium acetate, 16 mM magnesium acetate, 2 mMdithiothreitol, 6% polyethylene glycol (molecular weight: 1450-20000), 2.5 mM ATP, 30 mM phosphocreatine, 120 ng/ulcreatine kinase, 450 ng/uI VR7_25X_NHis protein, 700 ng/uI VR7G_NHis protein, 70 ng/uI VR7_25_26Y_NHis protein, 8 Units Staphylococcus aureus polymerase I klenow fragment (exo-), 450 uMdNTP, 250 nM forward primer, 250 nM reverse primer; the template was a plasmid sequence synthesized by Grass Carp Reovirus GCRV VP7 protein gene, and respectively diluted into 10,000,000 copies/uI, 1,000,000 copies/uI, 100,000 copies/uI,10,000 copies/uI, 1000 copies/uI,100 copies/uI,and 10 copies/uI; the negative control was NTC, and 1 uI template was added to the reaction system during reaction. A probe was used for detection, exoexcision enzyme III was used, and the final concentration was 50 ng/uI. Reaction conditions were as follows: 50 uI, amplification temperature was 28° C.

GCRV-I-F203: (SEQ ID NO. 53) 5′-CCCACGCCAACGTCAAGACCATTCAAGACTCC-3′ GCRV-I-PB: (SEQ ID NO. 54) 5′-CAAATGAAGCCATTCGCTCATTAGTCGAAG(Fam-dT) G(THF)G(BHQ1-dT)GACAAAGCGCAGACC(C3-SPACER)-3′ GCRV-I-R313: (SEQ ID NO. 55) 5′-TCCAATTCGTGATAGTCTACAGTACGGCTACC-3′

The sequence carrying Grass Carp Reovirus GCRV VP7 protein gene was as follows:

(SEQ ID NO. 56) 5′-ATTCTAGCTAGCATGCCACTTCACATGATTCCGCAAGTCGCCCACG CTATGGTGCGTGCAGCCGCTGCAGGACGCCTTACCTTATACACAAGAAC TAGAACTGAGACCACCAACTTTGATCACGCTGAGTACGTCACCTGCGGG CGGTACACCATCTGCGCCTTCTGCCTTACGACTCTGGCTCCCCACGCCA ACGTCAAGACCATTCAAGACTCCCACGCTTGTTCACGTCAACCAAATGA AGCCATTCGCTCATTAGTCGAAGTGAGTGACAAAGCGCAGACCGCCCTC GTCGGTAGCCGTACTGTAGACTATCACGAATTGGATGTGAAAGCTGGGT TCGTCGCCCCAACTGCCGATGAAACAATAGCCCCCTCTAAGGATATCGT CGAACTTCCGTTTCGCACCTGTGACTTGTACGATTCCTCTGCTACCGCT TGCGTCCGAAATCACTGCCAGGCCGGTCACGACGGCGTTATCCACCTCC CGATCCTTTCTGGAGATTTCAAATTGCCTAACGAGCATCCCACCAAACC GTTGGACGATACGCATCCCCACGACAAGGTGCTGACTCGCTGCCCCAAG ACTGGTCTCCTCCTCGTCCATGACACTCACGCACACGCCACCGCCGTAG TTGCCACCGCTGCTACGAGAGCTATCCTCATGCACGACCTCCTTACATC AGCGAACGCGGATGACGGCCATCAAGCACGTTCCGCTTGCTACGGTCCA GCGTTTAACAACCTGACCTTCGCTTGCCACTCCACCTGTGCTTCAGATA TGGCTCACTTCGACTGCGGCCAGATCGTTGGACTCGACTTGCATGTGGA GCCATCCGATTAACTCGAGCGGAAT-3′

The sequence was cloned onto a pUC57 vector, and the terminal sites were cut by an EcoR V enzyme.

The reaction was performed on a GenDx GS8 fluorescence amplifier, and the fluorescence scanning interval was 30 S, and the reaction time was 20 min.

S1: 10,000,000 copies/uI,

S2: 1,000,000 copies/uI,

S3: 100,000 copies/uI,

S4: 10,000 copies/uI,

S5: 1000 copies/uI,

S6: 100 copies/uI,

S7: 10 copies/uI,

S8: Negative control was NTC;

The test result (FIG. 10 ) shows that the S6 sample has very obvious amplification, while the S7 sample has slightly increased fluorescence signal. Therefore, the detection sensitivity may be not lower than 100 copies/uI, and close to the sensitivity detected by other molecular diagnostic techniques. By optimization directed to the primer and probe sequence, it should be expected to obtain more excellent effect, thus achieving the detection for the amplified fluorescence signal of a single copy.

Example IX Influence of a uvsX Variant Site on the Amplification Reaction

The reaction reagent and concentration thereof were as follows: 20 mMtris(hydroxymethyl) aminomethane-acetic acid buffer solution, 120 mM potassium acetate, 10 mM magnesium acetate, 6% polyethylene glycol (molecular weight: 1450-20000), 4 mM ATP, 45 mM phosphocreatine, 90 ng/ulcreatine kinase, 450 ng/uluvsX protein from 20 different variants, 550 ng/uI VR7G_CHis protein, 60 ng/uI VR7_25_26Y_NHis protein, 120 ng/uIStaphylococcus aureus polymerase I klenow fragment (exo-), 450 uMdNTP, 400 nM forward primer ARMP-F, 400 nM reverse primer ARMP-R, and about 3000 copies/uI plasmid template carrying a segment of Mycoplasma pneumoniae 16srDNA gene sequence; Sybr Green I had a concentration of 0.5X; the reaction conditions were as follows: 50 uI, and the amplification temperature was 34° C. The reaction was performed on an MolARRAY MA-6000 fluorescent quantitative PCR amplifier, and the fluorescence scanning interval was 30 S, and the reaction time was 20 min.

peu-F: (SEQ ID NO. 57) 5′-GCGAACGGGTGAGTAACACGTATCCAATCT-3′ peu-R2: (SEQ ID NO. 58) 5′-CAAAGTTCTTATGCGGTATTAGCTAGTCTT-3′

The result was shown in 11 (a)-(e). In FIG. 11 (a):

S1: VRX_Variant1 450 ng/uI; VR5G_NHis 550 ng/ul; VR5Y_NHis 60 ng/uI; S2: VRX_Variant2 450 ng/uI; VR5G_NHis 550 ng/ul; VR5Y_NHis 60 ng/uI; S3: VRX_Variant3 450 ng/uI; VR5G_NHis 550 ng/ul; VR5Y_NHis 60 ng/uI; S4: VRX_Variant4 450 ng/uI; VR5G_NHis 550 ng/ul; VR5Y_NHis 60 ng/uI; S5: VR5X_NHis 450 ng/uI; VR5G_NHis 550 ng/ul; VR5Y_NHis 60 ng/ul; NTC: VR5X_NHis 450 ng/ul; VR5G_NHis 550 ng/ul; VR5Y_NHis 60 ng/uI; there was no template.

In FIG. 11 (b):

S6: VRX_Variant5 450 ng/ul; VR7G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; S7: VRX_Variant6 450 ng/ul; VR7G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; S8: VRX_Variant7 450 ng/ul; VR7G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; S9: VRX_Variant8 450 ng/ul; VR7G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; S10: VR7_25X_NHis 450 ng/ul; VR7G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; NTC: VR7_25X_NHis 450 ng/ul; VR7G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; there was no template.

In FIG. 11 (c):

S11: VRX_Variant9 450 ng/ul; VR25G_NHis 550 ng/ul; VR20Y_NHis 60 ng/ul; S12: VRX_Variant10 450 ng/ul; VR25G_NHis 550 ng/ul; VR20Y_NHis 60 ng/ul; S13: VRX_Variant11 450 ng/ul; VR25G_NHis 550 ng/ul; VR20Y_NHis 60 ng/ul; S14: VRX_Variant12 450 ng/ul; VR25G_NHis 550 ng/ul; VR20Y_NHis 60 ng/ul; S15: VR20_26X_NHis 450 ng/ul; VR25G_NHis 550 ng/ul; VR20Y_NHis 60 ng/ul; NTC: VR20_26X_NHis 450 ng/ul; VR25G_NHis 550 ng/ul; VR20Y_NHis 60 ng/ul; there was no template.

In FIG. 11 (d):

S16: VRX_Variant13 450 ng/ul; VR7G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; S17: VRX_Variant14 450 ng/ul; VR7G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; S18: VRX_Variant15 450 ng/ul; VR7G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; S19: VRX_Variant16 450 ng/ul; VR7G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; S20: VR7_25X_NHis 450 ng/ul; VR7G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; NTC: VR7_25X_NHis 450 ng/ul; VR7G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; there was no template.

In FIG. 11 (e):

S21: VRX_Variant17 450 ng/ul; VR25G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; S22: VRX_Variant18 450 ng/ul; VR25G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; S23: VRX_Variant19 450 ng/ul; VR25G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; S24: VRX_Variant20 450 ng/ul; VR25G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; S25: VR20_26X_NHis 450 ng/ul; VR25G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; NTC: VR20_26X_NHis 450 ng/ul; VR25G_NHis 550 ng/ul; VR7_25_26Y_NHis 60 ng/ul; ng/ul; there was no template.

The test result shows that the amplifiation efficiency of partial variants is obviously higher than the wild-type uvsX protein at different variant sites,such as, VRX_Variant1, VRX_Variant7, VRX_Variant11, VRX_Variant17, and VRX_Variant18. Moreover, it is presumed according to the above experiment that other variants may be also superior to the wild-type protein in combination with different gp32 and uvsY proteins.

Example X Detection on a Cell Mycoplasma-Contaminated Sample

The reaction reagent and concentration thereof were as follows: 30 mMtris(hydroxymethyl) aminomethane-acetic acid buffer solution, 60 mM potassium acetate, 8 mM magnesium acetate, 4mMdithiothreitol, 5% polyethylene glycol (molecular weight: 20000), 3 mM ATP, 50 mM phosphocreatine, 30 ng/ul RM-CK, 360 ng/ul VR7_25X_NHis protein, 500 ng/ul VR7G_NHis protein, 60 ng/ul VR7_25_26Y_NHis protein, 8 Units Bacillus subtilis polymerase I klenow fragment (exo-), 450 uMdNTP, 250 nM forward primer susF, 250 nM reverse primer susR, about 10 ng/ul pork tissue genome DNA template, a probe susPB was used for detection, and the probe susPB had a final concentration was 120 nM, and exonuclease III (exo III) had a final concentration of 70 ng/ul.Reaction conditions were as follows: 50 uI. Moreover, a reagent TwistDx (www.twistdx.co.uk, Cat.No.: TALQBASO1) was used for the RPA technology; exonuclease III (exo III) having a final concentration of 70 ng/uI was further added as control, and other amplificationconditions were consistent. The amplification temperature: 20-45° C., a temperature gradient every other 5° C. There were six groups of reaction (20, 25, 30, 35, 40, and 45° C.). The reaction was performed on a GenDx GS8 fluorescence amplifier, and the fluorescence scanning interval was 30 S, and the reaction time was 40 min.

The experiment result was shown in FIG. 12 : left y-coordinate: change of fluorescence signal value; right y-coordinate: time of beginning to change of the scanningfluorescence value after reaction; x-coordinate denotes different temperatures (where, 45° C. was not listed since no amplification was detected for the two reagents). Bar graph: fluorescence signal change value after amplification at different temperature, where gray denotes low-temperature protein derived from VR7, black denotes a RPA amplification reagent of exonuclease III (exo III); broken line graph denotes change time of the fluorescence signal (TT), where gray denotes low-temperature protein derived from VR7, black denotesexonuclease III.

The amplification result proves that different from RPA amplification reagent, the low-temperature protein system derived from VR7 has more obvious amplification effect at a condition of 20-30° C., and the RPA amplification reagent has higher amplification efficiency at 35-40° C., which is consistent with the literature report. In this test, no amplified fluorescence signal change was detected for the RPA reagent at a condition of 20° C.

Example XI Detection on Whether there was Mycoplasma Contamination in a Cell Sample by Amplification of Combined Proteins VRX_Variant1, VR5G_NHis, VR5Y_NHis

The reaction reagent and concentration thereof were as follows: 100 mMtris(hydroxymethyl) aminomethane-acetic acid buffer solution, 120 mM potassium acetate, 15 mM magnesium acetate, 6mMdithiothreitol, 5% polyethylene glycol (molecular weight: 20000), 2 mM ATP, 40 mM phosphocreatine, 450 ng/uI VRX_Variant1,550 ng/uI VR5G_NHis,60 ng/uI VR5Y_NHis, 8 Units Bacillus subtilis polymerase I klenow fragment (exo-), 450 uMdNTP, and Sybr Green I 0.4X, 250 nM forward primer ARMP-F, 250 nM reverse primer ARMP-R, 120 nM fluorescent probe ARMP-PB; the primer and probe sequences were respectively as follows:

ARMP-F: (SEQ ID NO. 59) 5′-AGCATGTGGTTTAATTTGATGTTACGCGG-3′ ARMP-R: (SEQ ID NO. 60) 5′-CCATGCACCATCTGTCACTCCGTTAACCTCCG-3′

Reaction conditions were as follows: 50 uI, amplification temperature was 32° C. The sample was a cell culture fluid confirmed to be contaminated with mycoplasma; the fluorescence curve was detected after amplification.

Sample treatment: 500 μl cell supernatant (or the above cell suspension) was taken and centrifuged for 6 min at 14000 rpm; then supernatant was removed to collect precipitate (note: the supernatant may be absorbed by a sucker), and 50 I sterile water was added and vibrated evenly, heated in a 95° C. water bath for 3 min, then slightly vibrated and mixed evenly, after rapid centrifugation, a DNA template was released to the supernatant; during the reaction, 2.5 uI were taken and added to the system as a template.

The reaction was performed on a Bio-Rad Mini Opticon fluorescent quantitative PCR instrument, and the fluorescence scanning interval was 30 S, and the reaction time was 25 min.

The amplified result was shown in FIG. 13 .

In FIG. 13 :

S1: Sample No. 1

S2: Sample No. 2

S3: Sample No. 3

S4: Sample No. 4

S5: Sample No. 5 It is verified by amplification that the above samples may obtain positive amplification curves; according to different ct values, it is preliminarily presumed that No. 1 sample has more serious contamination.

REFERENCES

-   1. Yan L, Zhou J, Zheng Y, et al. -   Isothermal amplified detection of DNA and RNA[J].Molecular     Biosystems,2014,10(5):970-1003. -   2. Sinha N K, Morris C F, Alberts B M.Efficient in vitro replication     of double-stranded DNA templates by a purified T4 bacter iophage     replication system [J].Journal of Biological     Chemistry,1980,255(9):4290-4293. -   3. Alberts B M, Frey L.T4 Bacteriophage Gene 32:A Structural Protein     in the Replication and Recombination of DN     A[J].Nature,1970,227(5265):1313-1318. -   4. Formosa T, Burke R L, Alberts B M. -   Affinity purification of bacteriophage T4 proteins essential for DNA     replication and genetic recomb ination.[J].Proceedings of the     National Academy of Sciences of the United States of America,1983,     80(9):2442-2446. -   5. Yonesaki T, Ryo Y, Minagawa T, Takahashi H. -   Purification and some of the functions of the products of     bacteriophage T4 recombination genes, uvsX and uvsY Eur J     Biochem.1985 Apr 1; 148(1):127-34. -   6. Griffith J, Formosa T. -   The uvsX protein of bacteriophage T4 arranges single-stranded and     double-stranded DNA into simil ar helical nucleoprotein     filaments.[J].Journal of Biological Chemistry,1985,260(7):4484. -   7. Formosa T, Alberts B M. -   Purification and characterization of the T4 bacteriophage uvsX     protein.[J].Journal of Biological Che mistry,1986,261(13):6107-18. -   8. Minagawa T, Fujisawa H, Yonesaki T, et al. Function of cloned T4     recombination genes, uvsX and uvsY, in cells of Escherichia     coli.[J]. Molecular & General Genetics Mgg,1988,211(2):350-356. -   9. Harris L D, Griffith J D. -   UvsY protein of bacteriophage T4 is an accessory protein for in     vitro catalysis of strand exchange. J Mol Biol.1989 Mar 5;     206(1):19-27. -   10. Morrical S W, Alberts B M. -   The UvsY protein of bacteriophage T4 modulates     recombination-dependent DNA synthesis in vitro[J]. Journal of     Biological Chemistry, 1990, 265(25): 15096-15103. -   11. Beernink, H. T., and Morrical, S.W.(1999)     RMPPs:recombination/replication mediator proteins,Trends Biochem.     Sci.24, 385-389. -   12. Sweezy, M. A., and Morrical, S.W.(1999) Biochemical interactions     within a ternary complex of the bacteriophage T4 recombination     proteins uvsY and gp32 bound to single-stranded DNA, Biochemistry     38, 936-944. -   13. Beernink, H. T., and Morrical, S.W.(1998)The uvsY recombination     protein of bacteriophage T4 forms hexamers in the presence an d     absence of single-stranded DNA, Biochemistry 37, 5673-5681. -   14. Jie Liu, Jeffrey P. Bond, §,     and, Scott W. Morrical, §,     . -   Mechanism of Presynaptic Filament Stabilization by the Bacteriophage     T4 UvsY Recombination M ediator[J]. Biochemistry, 2006, 45(17):5493. -   15. Pant K, Shokri L, Karpel R L, et al.Modulation of T4 gene 32     protein DNA binding activity by the recombination mediator protein     UvsY[J]. Journal of Molecular Biology, 2008, 380(5): 799-811. -   16. U.S. Pat. No. 5,223,414 to Zarling et al. -   17. Formosa T, Alberts B M. DNA synthesis dependent on genetic     recombination: characterization of a reaction catalyzed by purified     bacteriophage T4 proteins[J]. Cell, 1986, 47(5): 793-806. -   18. Morrical S W, Wong M L, Alberts B M. -   Amplification of snap-back DNA synthesis reactions by the uvsX     recombinase of bacteriophage T4. [J]. Journal of Biological     Chemistry, 1991, 266(21): 14031. -   19. Salinas F, Jiang H, Kodadek T. -   Homology dependence of UvsX protein-catalyzed joint molecule     formation.[J]. -   Journal of Biological Chemistry, 1995, 270(10): 5181-6. -   20. Morel P, Cherny D, Ehrlich S D, et al. -   Recombination-dependent repair of DNA double-strand breaks with     purified proteins from Escheric hia coli.[J]. Journal of Biological     Chemistry, 1997, 272(27): 17091-6. -   21. International patent application WO 02/086167, Benkovic and     Salinas -   22. Piepenburg, Olaf, Williams,Colin H.; Stemple,Derek L.; Armes,     Niall A. (2006). “DNA Detection Using Recombination Proteins”. PLoS     Biology. 4(7): e204. Doi: 10.1371/journal. -   Pbio. 0040204. PMC 1475771. PMID 16756388. -   23. Comeau A M, Bertrand C, Letarov A, Te{acute over (t)}art F,     Krisch H M (2007) Modular architecture of the T4 phage superfamily:a     conserved core genome and a plastic periphery. -   Virology 362: 384-396. doi:10. 1016/J. virol.2 -   24. Ackermann H-W, Krisch H M (1997) A catalogue of T4-type     bacteriophages.Arch Virol 142:2329-2345 -   25. Leclerc H, Mossel DAA, Edberg SC, Struijk CB (2001) Advances in     the bacteriology of the coliform group:their suitability as markers     of microbial water sa fety. Annu Rev Microbiol 55:201-234 -   26. Fileé J, Te{acute over (t)}art F, Suttle C A, Krisch H M (2005)     Marine T4-type bacteriophages, a ubiquitous component of the dark     matter of the biosphere. Proc Natl Acad Sci USA 102: 12471-12476. -   27. Seeley N D, Primrose S B (1980) The effect of temperature on the     ecology of aquatic bacteriophages. J Gen Virol 46: 87-95 -   28. J. Written by Sambrook, et al., and translated by Huang Peitang,     et al. Molecular Cloning, Version III, Science Press. 2002 -   29. YASUO IMAE, et al, Replication of T4 DNA In Vitro II. -   Assay System for and Some Properties of Gene Products Required for     T4 DNA Replication. -   JOURNAL OF VIROLOGY, 1976, Vol. 19, No. 3 p.765-774 -   30. Alberts, B.M., and L. Frey. 1970. T4 bacteriophage gene 32: -   a structural protein in the replication and recombination of     DNA.Nature (London) 227: 1313-1318. -   31. Fujisawa, H., Yonesaki, T.& Minagawa,T.(1985). Sequence of the     T4 recombination gene, uvsX, and its comparison with that of the     recA gene of Escherichia coli. Nucl. Acids Res. 13, 7473-7481. -   32. Hinton, D. M. et al. -   Cloning of the bacteriophage T4 uvsX gene and purification and     characterization of the T4 uvsX rec ombination protein. 1986, Vol.     261, No. 12, Issue of April 25, pp. 5663-5673 -   33. et al. -   Inhibition of Holliday structure resolving endonuclease VII of     bacteriophage T4 by recombination e nzymes UvsX and UvsY J. Mol.     Biol. (1997) 267, 150-162 -   34. Wu C L, Li Y H, Lin H C, Yeh Y H, Yan H Y, Hsiao C D, Hui C F,     Wu J L. -   Activity and function of rabbit muscle-specific creatine kinase at     low temperature by mutation at gl y268 to asn268. Comp Biochem     Physiol B Biochem Mol Biol.2011 Mar; 158(3): 189-98. Doi: 10.1016/j.     cbpb. 2010.11.009. Epub 2010 Dec 3. -   35. Wu C L, Li B Y, Wu J L, Hui C F. -   The activity of carp muscle-specific creatine kinase at low     temperature is enhanced by decreased hy drophobicity of residue 268.     Physiol Biochem Zool. 2014 Jul-Aug; 87(4): 507-16. doi:10.     1086/676466. Epub 2014 Jun 3. 

1-10. (canceled)
 11. A room temperature nucleic acid amplification reaction system, wherein the system comprises: a cold-active bacteriophage uvsX protein, a uvsY protein or a gp32 protein; and/or a variant protein having the same function with the cold-active bacteriophage uvsX protein, the cold-active bacteriophage uvsY protein or the cold-active bacteriophage gp32 protein respectively.
 12. The room temperature nucleic acid amplification reaction system according to claim 11, wherein the cold-active bacteriophage uvsX protein is selected from any sequence of SEQ ID Nos. 21-23 and 30 or a sequence having 98% and more homology to the above sequence.
 13. The room temperature nucleic acid amplification reaction system according to claim 11, wherein the uvsX variant protein is selected from any sequence of SEQ ID Nos. 1-20 or a sequence having 98% and more homology to the above sequence.
 14. The room temperature nucleic acid amplification reaction system according to claim 11, wherein the cold-active bacteriophage uvsY protein is selected from any sequence of SEQ ID Nos. 27-29 and 32 or a sequence having 98% and more homology to the above sequence.
 15. The room temperature nucleic acid amplification reaction system according to claim 11, wherein the cold-active bacteriophage gp32 protein is selected from any sequence of SEQ ID Nos. 24-26 and 31 or a sequence having 98% and more homology to the above sequence.
 16. The room temperature nucleic acid amplification reaction system according to claim 11, wherein the system further comprises a polymerase, a nuclease, dNTP, a crowding agent, an energy substance, a creatine kinase and/or a salt ion.
 17. The room temperature nucleic acid amplification reaction system according to claim 16, wherein the polymerase is selected from any one or a combination of more than one of an Escherichia coli polymerase klenow fragment (exo-), a Staphylococcus aureus polymerase I klenow fragment (exo-), a Bacillus subuilis polymerase I klenow (exo-), a Pseudomonas fluorescens polymerase I klenow (exo-), and variants or klenow fragments of these enzymes.
 18. The room temperature nucleic acid amplification reaction system according to claim 16, wherein the crowding agent is selected from any one or a combination of more than one of polyethylene glycol, polyvinyl alcohol, dextran or polysucrose.
 19. The room temperature nucleic acid amplification reaction system according to claim 18, wherein the polyethylene glycol is selected from one or more of PEG1450, PEG3000, PEG8000, PEG10000, PEG14000, PEG20000, PEG25000 and PEG30000.
 20. The room temperature nucleic acid amplification reaction system according to claim 16, wherein the energy system is selected from a combination of ATP or ATP, phosphocreatine or creatine kinase.
 21. The room temperature nucleic acid amplification reaction system according to claim 16, wherein the salt ion is selected from any one or a combination of more than one of Tris, magnesium ion or potassium ion.
 22. The room temperature nucleic acid amplification reaction system according to claim 16, wherein in the system, the polymerase is the Staphylococcus aureus polymerase I klenow fragment (exo-), the Bacillus subtilis polymerase I klenow fragment (exo-), the Pseudomonas fluorescens polymerase I klenow fragment (exo-), or a combination thereof.
 23. The room temperature nucleic acid amplification reaction system according to claim 16, wherein in the system, the creatine kinase is preferably a variant on which G in position 268 is mutated into N.
 24. The room temperature nucleic acid amplification reaction system according to claim 11, wherein in the system, the system has a reaction temperature of 20-40° C.
 25. The room temperature nucleic acid amplification reaction system according to claim 11, wherein a reaction temperature is 25-37° C., and a reaction time is 20-40 min.
 26. The room temperature nucleic acid amplification reaction system according to claim 11, wherein the system further comprises a primer sequence and a template sequence.
 27. The room temperature nucleic acid amplification reaction system according to claim 11, wherein the system further comprises a fluorescent probe sequence.
 28. The room temperature nucleic acid amplification reaction system according to claim 12, wherein the protein sequence is encoded by a corresponding nucleotide sequence.
 29. A protein as shown in any one of SEQ ID Nos. 1-20 or a protein having the same function therewith and 98% and more homology thereto. 